Clinical Trials Sponsored by Dong-A Pharmaceutical
Total 852 results
-
Chong Kun Dang PharmaceuticalCompletedHypertensionKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedDyslipidemiaKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedReflux EsophagitisKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedAcute Gastritis | Chronic GastritisKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedRheumatoid ArthritisKorea, Republic of
-
Chong Kun Dang PharmaceuticalUnknownDiabetes Mellitus, Type 2Korea, Republic of
-
Chong Kun Dang PharmaceuticalCompleted
-
Chong Kun Dang PharmaceuticalCompleted
-
Chong Kun Dang PharmaceuticalCompleted
-
Chong Kun Dang PharmaceuticalCompleted
-
Chong Kun Dang PharmaceuticalCompletedImmunosuppressionKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedHypertensionKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedEssential Hypertension | HyperlipidemiaKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedDiabetes Mellitus, Type 2Korea, Republic of
-
Chong Kun Dang PharmaceuticalCompleted
-
Chong Kun Dang PharmaceuticalCompletedGastrointestinal Stromal Tumors | Chronic Myeloid LeukemiaKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompleted
-
Chong Kun Dang PharmaceuticalCompletedDyslipidemia
-
Chong Kun Dang PharmaceuticalCompleted
-
Chong Kun Dang PharmaceuticalCompletedHealthyKorea, Republic of
-
Daiichi Sankyo Hong Kong Ltd., a Daiichi Sankyo...CompletedAtrial FibrillationHong Kong
-
Chong Kun Dang PharmaceuticalRecruiting
-
Chong Kun Dang PharmaceuticalRecruitingKidney TransplantKorea, Republic of
-
Chong Kun Dang PharmaceuticalRecruitingType 2 DiabetesKorea, Republic of
-
Chong Kun Dang PharmaceuticalRecruitingCOVID-19 PneumoniaKorea, Republic of
-
Chong Kun Dang PharmaceuticalNot yet recruitingKidney TransplantationKorea, Republic of
-
Chong Kun Dang PharmaceuticalActive, not recruitingType II Diabetes MellitusKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompleted
-
Chong Kun Dang PharmaceuticalCompletedKidney TransplantKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedEndocrine, Nutritional and Metabolic DiseasesKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedType II DiabetesKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedDiabetes type2Korea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedHealthy SubjectsUnited Kingdom
-
Chong Kun Dang PharmaceuticalCompleted
-
Chong Kun Dang PharmaceuticalCompletedClinical Study to Compare the Pharmacokinetics and Safety of D113 With CKD-349 in Healthy VolunteersChronic Renal FailureKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedHypertension and DyslipidemiaKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompleted
-
Chong Kun Dang PharmaceuticalCompletedDyslipidemiasKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedHypertensionKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedHypertension and DyslipidemiaKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedHypertension and DyslipidemiaKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompleted
-
Chong Kun Dang PharmaceuticalCompletedAlopeciaKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedHypertension and DyslipidemiaKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedType 2 Diabetes MellitusKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedEfficacy and Safety of CKD-501 Added to D150 Plus D745 10mg Therapy in Patients With Type 2 DiabetesType2 DiabetesKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompleted
-
Chong Kun Dang PharmaceuticalCompletedChronic Hepatitis BKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompleted